Analysis of α-synuclein levels related to LRRK2 kinase activity: from substantia nigra to urine of patients with Parkinson’s disease
Research on Parkinson’s disease (PD) has been focused on the development of PD diagnostic tools as much as the development of PD therapeutics. Several genetic culprits of PD, including DJ-1, Leucine-rich repeat kinase 2 (LRRK2), and α-synuclein (α-syn), have been investigated as markers of PD in hum...
Main Authors: | Daleum Nam, Ami Kim, Sun Jung Han, Sung-Ik Lee, Sung-Hye Park, Wongi Seol, Ilhong Son, Dong Hwan Ho |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2021-01-01
|
Series: | Animal Cells and Systems |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/19768354.2021.1883735 |
Similar Items
-
The C-Terminal Domain of LRRK2 with the G2019S Substitution Increases Mutant A53T α-Synuclein Toxicity in Dopaminergic Neurons In Vivo
by: Noémie Cresto, et al.
Published: (2021-06-01) -
Increase in anti-apoptotic molecules, nucleolin, and heat shock protein 70, against upregulated LRRK2 kinase activity
by: Jihoon Jang, et al.
Published: (2018-09-01) -
Alzheimer’s disease tau is a prominent pathology in LRRK2 Parkinson’s disease
by: Michael X. Henderson, et al.
Published: (2019-11-01) -
LRRK2 inhibition does not impart protection from α-synuclein pathology and neuron death in non-transgenic mice
by: Michael X. Henderson, et al.
Published: (2019-02-01) -
Expression of transduced nucleolin promotes the clearance of accumulated α-synuclein in rodent cells and animal model
by: Dong Hwan Ho, et al.
Published: (2021-07-01)